DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 0.00 0.00%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo


35.49 -0.91 (-2.50%)

Quote as of

company name or ticker

Recent Quotes

TSRO $35.49 -2.50%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $36.80
Previous Close $36.40
Daily Range $34.27 - $37.62
52-Week Range $32.50 - $66.95
Market Cap $1.4B
P/E Ratio -9.71
Dividend (Yield) $0.00 (0.0%)
Volume 868,422
Average Daily Volume 534,126
Current FY EPS -$6.28




Drug Makers

TESARO (TSRO) Description

TESARO Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. Website:

News & Commentary Rss Feed

Why Opko Health's Shares Fell 20% in January

A broad-based sell off in biotech caused shares in this emerging healthcare play to tumble.

First Week of September 16th Options Trading For Tesaro (TSRO)

Commit To Buy Tesaro At $25, Earn 20.9% Annualized Using Options

Tesaro Enters Oversold Territory (TSRO)

Why Opko Health Inc.'s Stock Rallied 15% in November

A recent approval and a pending FDA decision make this company one to watch in 2016.

3 Predictions for Opko Health Inc. in 2016

What does the new year hold for this up-and-coming biotech?

TSRO Makes Bullish Cross Above Critical Moving Average

How Big Could This Drug Be for Opko Health?

The approval of Varubi could generate meaningful royalty revenue over time.

Opko Health's New Era Begins

An acquisition, an approval, another potential approval, and key trial results set the stage for a transformative 2016.

David Swensen's Transactions Show Diversity of Portfolio

See More TSRO News...